Skip to main content
Edwards Lifesciences Logo

Surgical mitral pericardial valves

mitral pericardial
mitral pericardial
mitral pericardial
mitral valve
mitral valve
mitral valve

Carpentier-Edwards PERIMOUNT Magna Mitral Ease valve

Built upon the unique and proven PERIMOUNT design, the Magna Mitral Ease valve gives you and your patients:

  • Ultra-low profile, with reduced ventricular projection by up to 40%
  • Exceptional long-term durability1-7
  • Ease of implant

The Magna Mitral Ease valve is built upon the proven, time-tested PERIMOUNT valve design, with unique design elements including:

  • Mathematically modeled, bioengineered design. Intended to optimize implantability, hemodynamics and long-term durability
  • Flexible cobalt-chromium alloy stent. Absorbs energy to reduce leaflet stress
  • Three independent bovine pericardial leaflets. Matched for thickness and elasticity to optimize stress distribution

‡ As compared to the Carpentier-Edwards PERIMOUNT Theon mitral valve.

Magna Mitral Ease heart valve

Model 7300TFX Nominal Specifications (mm)Size 25Size 27Size 29Size 31Size 33
A. Stent Diameter (Wireform)2527293131
B. Tissue Annulus Diameter2829.531.533.533.5
C. External Sewing Ring Diameter3638404244
D. Anterior Effective Profile77.588.58.5
model 7300FTX
model 7300FTX
model 7300FTX

* No clinical data are available that evaluate the long-term impact of the Edwards Lifesciences tissue treatments in patients.

References:

  1. Jamieson WRE, et al. Structural Valve Deterioration in Mitral Replacement Surgery: Comparison of Carpentier-Edwards Supra-Annular Porcine and PERIMOUNT Pericardial Bioprostheses. J Thorac Cardiovasc Surg. 1999 Aug;118:297-305. (Freedom from explant due to structural valve deterioration; n = 429; mean age = 60.7 ± 11.7 yrs)
  2. Aupart MR, et al. Carpentier-Edwards pericardial valves in the mitral position: ten-year follow-up. J Thorac Cardiovasc Surg. 1997 Mar;113(3):492-8. (Freedom from structural deterioration; n = 150; mean age = 62.9 ± 11.9 yrs)
  3. Murakami T, et al. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results. J Heart Valve Dis. 1996 Jan;5(1):45-9. (Freedom from structural deterioration; n = 57; mean age = 55.1 ± 13.2 yrs)
  4. Poirier NC, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66:S57-61. (Freedom from structural deterioration; n = 214; mean age = 65 ± 23 yrs)
  5. Neville PH, et al. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg. 1998;66(6 Suppl):S143-7. (Freedom from structural deterioration; n = 182; mean age = 63.9 ± 11.5 yrs)
  6. Marchand MA, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg. 2001 May;71(5 Suppl):S236-9. (Freedom from structural valve deterioration; n = 435; mean age = 60.7 ± 11.6 yrs)
  7. Bourguignon, T, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25 year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014 Nov;148:2004-11. (Freedom from explant due to structural valve deterioration; n = 404; mean age = 68.0 ± 10.4 yrs)
  8. Carpentier-Edwards PERIMOUNT pericardial bioprosthesis 16-year results. Data on file at Edwards Lifesciences, 2003. (Freedom from explant due to structural valve deterioration; n = 435; mean age = 60.7 ± 11.6 yrs)